|
|
| | Meperidine-D4.HCl (Pethidine-D4.HCl) Basic information |
| Product Name: | Meperidine-D4.HCl (Pethidine-D4.HCl) | | Synonyms: | 1-methyl-4-phenyl-4-piperidine-d4-carboxylicacid,ethylester,monohydrochloride;Meperidine-D4.HCl (Pethidine-D4.HCl), 1mg/ml in Methanol (as free base);Meperidine-D4.HCl (Pethidine-D4.HCl);Meperidine-D4.HCl (Pethidine-D4.HCl), 0.1mg/ml in Methanol (as free base);ethyl 3,3,5,5-tetradeuterio-1-methyl-4-phenylpiperidine-4-carboxylate | | CAS: | 2748469-74-9 | | MF: | C15H17D4NO2.ClH | | MW: | 287.82 | | EINECS: | | | Product Categories: | | | Mol File: | 2748469-74-9.mol |  |
| | Meperidine-D4.HCl (Pethidine-D4.HCl) Chemical Properties |
| | Meperidine-D4.HCl (Pethidine-D4.HCl) Usage And Synthesis |
| Description | Meperidine-d4 (hydrochloride) (CRM) is a certified reference material intended for use as an internal standard for the quantification of meperidine by GC- or LC-MS. Meperidine is categorized as an opioid.1 It is an opioid analgesic that is commonly abused.2 Meperidine is regulated as a Schedule II compound in the United States. Meperidine-d4 (hydrochloride) (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | | References | 1. Ossipov, M.H., Harris, S., Lloyd, P., et al. Antinociceptive interaction between opioids and medetomidine: Systemic additivity and spinal synergy Anesthesiology 73(6),1227-1235(1990). 2. Atluri, S.A., Sudarshan, G., and Manchikanti, L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011 Pain Physician 17(2),E119-E128(2014). |
| | Meperidine-D4.HCl (Pethidine-D4.HCl) Preparation Products And Raw materials |
|